IEI completes Arysta acquisition
The Irish-based investment firm, Industrial Equity Investments (IEI), has completed the acquisition of Arysta LifeScience following regulatory approval. Arysta was bought for around ¥50,000 million ($2,400 million) from investment firm Olympus Capital Holdings (Agrow No 530, p 1). IEI is part of private equity firm Permira (St Peter Port, Guernsey). Permira's investment will help maintain and accelerate Arysta's growth, both organically and through strategic acquisitions, says Chris Richards, Arysta's chief executive officer.